These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38087367)

  • 21. SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU).
    Vistica BP; Shi G; Nugent L; Tan C; Altman A; Gery I
    Mol Vis; 2012; 18():1858-64. PubMed ID: 22815639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of T cell-mediated inflammation in uveitis by a novel anti-CD3 antibody.
    Sugita S; Shimizu J; Makabe K; Keino H; Watanabe T; Takahashi M
    Arthritis Res Ther; 2017 Jul; 19(1):176. PubMed ID: 28743289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective Arrestin-Specific Immunotherapy of Experimental Autoimmune Uveitis with RTL: A Prospect for Treatment of Human Uveitis.
    Kyger M; Worley A; Huan J; McDowell H; Smith WC; Burrows GG; Mattapallil MJ; Caspi RR; Adamus G
    Transl Vis Sci Technol; 2013 Feb; 2(2):1. PubMed ID: 24049712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the Notch signaling pathway disturbs the CD4
    Yin X; Liu B; Wei H; Wu S; Guo L; Xu F; Liu T; Bi H; Guo D
    Inflamm Res; 2019 Sep; 68(9):761-774. PubMed ID: 31209505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of the Reactive Oxygen Response Alleviates Experimental Autoimmune Uveitis in Mice.
    Hsu SM; Yang CH; Teng YT; Tsai HY; Lin CY; Lin CJ; Shieh CC; Chen SH
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subretinal Transplantation of Human Amniotic Epithelial Cells in the Treatment of Autoimmune Uveitis in Rats.
    Li J; Qiu C; Zhang Z; Yuan W; Ge Z; Tan B; Yang P; Liu J; Zhu X; Qiu C; Lai D; Guo L; Yu L
    Cell Transplant; 2018 Oct; 27(10):1504-1514. PubMed ID: 30168350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineered procyanidin-Fe nanoparticle alleviates intestinal inflammation through scavenging ROS and altering gut microbiome in colitis mice.
    Chang Y; Wu X; Lu S; Du J; Long Y; Zhu Y; Qin H
    Front Chem; 2023; 11():1089775. PubMed ID: 37065822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total glucosides of paeony suppresses experimental autoimmune uveitis in association with inhibition of Th1 and Th2 cell function in mice.
    Huang XT; Wang B; Zhang WH; Peng MQ; Lin D
    Int J Immunopathol Pharmacol; 2018; 32():394632017751547. PubMed ID: 29363368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amelioration of experimental autoimmune uveitis by leflunomide in Lewis rats.
    Fang CB; Zhou DX; Zhan SX; He Y; Lin Z; Huang C; Li J
    PLoS One; 2013; 8(4):e62071. PubMed ID: 23626769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tofacitinib inhibits the development of experimental autoimmune uveitis and reduces the proportions of Th1 but not of Th17 cells.
    Bing SJ; Lyu C; Xu B; Wandu WS; Hinshaw SJ; Furumoto Y; Caspi RR; Gadina M; Gery I
    Mol Vis; 2020; 26():641-651. PubMed ID: 33088168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanozyme-mediated catalytic nanotherapy for inflammatory bowel disease.
    Zhao J; Gao W; Cai X; Xu J; Zou D; Li Z; Hu B; Zheng Y
    Theranostics; 2019; 9(10):2843-2855. PubMed ID: 31244927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. S-nitrosoglutathione prevents interphotoreceptor retinoid-binding protein (IRBP(161-180))-induced experimental autoimmune uveitis.
    Haq E; Rohrer B; Nath N; Crosson CE; Singh I
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):221-31. PubMed ID: 17593005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multifunctional Interleukin-24 Resolves Neuroretina Autoimmunity via Diverse Mechanisms.
    Zhang X; Hu C; Zhong Y; Qiao D; Chi W; Shen H; Chong W
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aminooxy-Acetic Acid Inhibits Experimental Autoimmune Uveitis by Modulating the Balance between Effector and Regulatory Lymphocyte Subsets.
    Mei S; Huang Y; Li N; Xu Z; Xu J; Dai Q; Wu J; Kijlstra A; Yang P; Hou S
    Curr Mol Med; 2020; 20(8):624-632. PubMed ID: 32072910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Will the Bacteria Survive in the CeO
    Zhu W; Wang L; Li Q; Jiao L; Yu X; Gao X; Qiu H; Zhang Z; Bing W
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34205408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects and mechanism of copper oxide nanozymes on wound healing of full-thickness skin defects in diabetic mice].
    Peng Y; Lu YF; Deng J; Zhang Y
    Zhonghua Shao Shang Za Zhi; 2020 Dec; 36(12):1139-1148. PubMed ID: 33379850
    [No Abstract]   [Full Text] [Related]  

  • 38. Multifunctional Nanozyme Hydrogel with Mucosal Healing Activity for Single-Dose Ulcerative Colitis Therapy.
    Cheng C; Cheng Y; Zhao S; Wang Q; Li S; Chen X; Yang X; Wei H
    Bioconjug Chem; 2022 Jan; 33(1):248-259. PubMed ID: 34936326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TMP778, a selective inhibitor of RORĪ³t, suppresses experimental autoimmune uveitis development, but affects both Th17 and Th1 cell populations.
    Lyu C; Bing SJ; Wandu WS; Xu B; Shi G; Hinshaw SJ; Lobera M; Caspi RR; Lu L; Yang J; Gery I
    Eur J Immunol; 2018 Nov; 48(11):1810-1816. PubMed ID: 30218573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SOCS3 deletion in T lymphocytes suppresses development of chronic ocular inflammation via upregulation of CTLA-4 and expansion of regulatory T cells.
    Yu CR; Kim SH; Mahdi RM; Egwuagu CE
    J Immunol; 2013 Nov; 191(10):5036-43. PubMed ID: 24101549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.